查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球食品成分市場：按類型、應用、形式、功能、地區分類 - 預測至 2029 年
市場調查報告書
商品編碼
1526809

全球食品成分市場：按類型、應用、形式、功能、地區分類 - 預測至 2029 年

Nutraceutical Ingredients Market by Type (Proteins, Amino Acids, and Probiotics), Application (Food, Beverages, Animal Nutrition, Dietary Supplements, Food For Special Medical Purposes (FSMP)), Form, Function, & Region - Global Forecast to 2029
出版日期: | 出版商: MarketsandMarkets | 英文 618 Pages | 訂單完成後即時交付

價格

全球營養補充品食品市場規模呈現顯著擴張趨勢，預計將從2024年的1,052億美元增加到2029年的1,361億美元，複合年複合成長率（CAGR）高達5.3%。

調查範圍
調查年份 2024-2029
基準年 2023年
預測期 2024-2029
考慮單位 金額（美元）、數量（千噸）
按細分市場 按類型、用途、形式、功能、地區
目標區域 北美、歐洲、亞太、南美等地區

為了應對普遍存在的營養不良問題，各國政府和非政府組織 (NGO) 正在推動強調營養重要性的措施。例如，大規模的食品強化工作大大增加了全球對強化食品的採用。這些努力得到了 PATH（健康適當技術計劃）等組織的支持。事實證明，PATH 的強化米 (UltraRice)舉措在布隆迪、印度、巴西和其他國家具有可擴展性和有效性，影響著法律規範和營養政策。除了解決營養缺乏問題外，這些措施還制定了促進食品加工中使用強化成分的指南。

在動物營養領域，食品成分在改善飼料配方方面變得越來越受歡迎。改良的飼料添加劑旨在改善動物健康、生長效率和產品品質，滿足全球對優質蛋白質來源不斷成長的需求。

行業內的合作將進一步加速市場擴張。例如，Olam Agri Holdings Pte Ltd 正在致力於大規模強化主食中必需的微量營養素，到 2030 年，每天可能惠及數百萬人。這些努力將加速強化食品在全球的採用，同時促進該產業致力於永續性和公共衛生。隨著持續的技術創新、監管支援和跨部門合作，該市場預計將進一步成長，營養保健食品作為全球健康促進舉措的關鍵組成部分的未來前景預計將得到鞏固。

為滿足個人營養需求而專門製備的食品，通常與疾病或醫療狀況相關，稱為特殊醫療用途食品。糖尿病、胃腸道疾病和METABOLIC INC.症候群等慢性疾病和病症的盛行率不斷上升，是推動特醫食品中食品成分需求不斷成長的主要因素。

此外，食物過敏和不耐症的普遍存在增加了對不含過敏原並根據個人飲食限制量身定做的專門 FSMP 配方的需求。因此，需要添加不僅安全而且能夠滿足營養需求且無副作用的營養保健食品。透過開發醫療營養療法提供支援的監管機構也透過認可成分配方的創新，同時確保滿足嚴格的健康標準來推動這一領域的發展。

本報告研究了全球營養補充劑食品市場，並按類型、應用、形式、功能、地區和參與市場的公司概況總結了趨勢。

目錄

第1章簡介

第2章調查方法

第3章執行摘要

第 4 章重要考察

第5章市場概況

  • 介紹
  • 總體經濟指標
  • 市場動態

第6章 產業趨勢

  • 介紹
  • 影響客戶業務的趨勢/干擾
  • 價格分析
  • 價值鏈分析
  • 生態系統
  • 技術分析
  • 專利分析
  • 貿易分析
  • 2024-2025年重大會議和活動
  • 關稅和監管狀況
  • 波特五力分析
  • 主要相關人員和採購標準
  • 案例研究分析
  • 投資金籌措場景
  • GEN AI 對食品和飲料成分和添加劑的影響

第7章營養補充品食品市場（按類型）

  • 介紹
  • 蛋白質
  • 胺基酸
  • 纖維和特殊碳水化合物
  • 益生菌
  • 植物化學物質和植物萃取物
  • 益生元
  • 功能性油脂
  • 維他命
  • 礦物
  • 類胡蘿蔔素
  • 其他

第8章營養補充食品市場（依用途）

  • 介紹
  • 食品
  • 飲料
  • 動物營養
  • 膳食食品
  • 特殊醫學用途食品(FSMP)

第9章營養補充食品市場（分形式）

  • 介紹
  • 乾燥
  • 液體

第10章營養補充食品市場（依功能分）

  • 介紹
  • 額外的補充品
  • 藥物補充品
  • 運動營養

第11章營養補充食品市場（分地區）

  • 介紹
  • 北美洲
  • 歐洲
  • 亞太地區
  • 南美洲
  • 其他地區

第12章競爭格局

  • 概述
  • 主要參與企業的策略/秘密
  • 收益分析
  • 2023 年市場佔有率分析
  • 企業評估矩陣：主要參與企業，2023
  • 企業評估矩陣：Start-Ups/小型企業，2023 年
  • 企業價值評估及財務指標
  • 品牌/產品比較
  • 競爭格局及趨勢

第13章 公司簡介

  • 主要參與企業
    • CARGILL, INCORPORATED
    • ADM
    • INTERNATIONAL FLAVORS & FRAGRANCES INC.
    • BASF SE
    • ARLA FOODS AMBA
    • DSM-FIRMENICH
    • INGREDION
    • TATE & LYLE
    • AJINOMOTO CO., INC.
    • ASSOCIATED BRITISH FOODS PLC
    • CHR. HANSEN A/S
    • KYOWA KIRIN CO., LTD
    • GLANBIA PLC
    • FONTERRA CO-OPERATIVE GROUP LIMITED
    • KERRY GROUP PLC
  • 其他公司
    • DIVI'S LABORATORIES LIMITED
    • ROQUETTE FRERES
    • BENEO
    • KEMIN INDUSTRIES, INC.
    • GOLDEN GRAIN GROUP LIMITED
    • COSUCRA
    • PURIS
    • PROEON
    • CONAGEN, INC.
    • CHICKP

第14章 鄰近市場及相關市場

第15章附錄

Product Code: FB 2211

The global nutraceutical ingredients market is on a trajectory of significant expansion, with an estimated value projected to reach USD 136.1 billion by 2029 from the 2024 valuation of USD 105.2 billion, displaying a promising Compound Annual Growth Rate (CAGR) of 5.3%.

Scope of the Report
Years Considered for the Study2024-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD), Volume (Kilo Ton)
SegmentsBy Type, Application, Form, Function (Qualitative), And Region
Regions coveredNorth America, Europe, Asia Pacific, South America, and RoW

"Regulatory support and collaborative efforts across public and private sectors in eradicating undernourishment fuels the demand for nutraceutical ingredients market."

In order to combat widespread deficiencies, governments and non-governmental organisations (NGOs) are championing initiatives that highlight the significance of nutrition. Large-scale food fortification initiatives, for instance, have greatly increased the global adoption of fortified foods. These initiatives are supported by organisations such as PATH (Program for Appropriate Technology in Health). PATH's nutrient-fortifying rice kernels (UltraRice) initiative has proven scalable and effective in Burundi, India, Brazil, and other countries, impacting regulatory frameworks and nutritional policies. In addition to addressing nutritional deficiencies, these initiatives establish guidelines that promote the use of fortified ingredients in food processing.

Nutraceutical ingredients are becoming more and more popular in animal nutrition to improve feed formulations. Improved feed additives aim to enhance animal health, growth efficiency, and product quality, meeting the rising demand for high-quality protein sources globally.

Partnerships within the industry further accelerate market expansion. For instance, Olam Agri Holdings Pte Ltd has committed to fortifying staple foods with essential micronutrients at scale, so millions can be reached every day by 2030. Such initiatives promote the industry's dedication to sustainability and public health while accelerating the global uptake of fortified foods. The market is anticipated to grow further due to ongoing innovation, regulatory support, and cross-sector collaboration, solidifying nutraceutical ingredients' position as a key component of global health and wellness initiatives in the future.

"During the forecast period, the food for special medical purposes (FSMP) within the application segment is estimated to witness the highest CAGR in the nutraceutical ingredients market."

Food specially prepared to meet special, often disease- or medical-condition-related nutritional requirements of individuals is known as food for special medical purposes. The increasing prevalence of chronic diseases and disorders, such as diabetes, gastrointestinal problems, metabolic syndromes, and others, has been the primary driver for the ever-growing demand for nutraceutical ingredients in FSMP. For instance, the IDF Diabetes Atlas for 2021 estimates that 1 in 10 adults worldwide, or 537 million adults aged 20 to 79, have diabetes at present. By 2030, this number is expected to rise to 643 million, and by 2045, it is expected to reach 783 million. Among the specific health benefits that nutraceutical ingredients provide to these patient populations are symptom management, improved nutritional intake, and support for overall health.

Moreover, the prevalence of food allergies and intolerances has heightened the need for specialized FSMP formulations that are free from allergens and tailored to individual dietary restrictions. This necessitates the addition of nutraceutical ingredients that are not only safe but have the efficacy to meet nutritional requirements without adverse reactions. Regulatory agencies, which provide support through developments in medical nutrition therapies, are also boosting this segment by ensuring that stringent health standards are met while allowing innovations in ingredient formulation.

"High healthcare costs driving demand for preventive healthcare have positioned the US in North America region as the dominant market in the nutraceutical ingredients market."

The US holds a dominant position in the North American nutraceutical ingredients market. There is a great need for preventive healthcare solutions due to the high cost of healthcare in the country. According to a piece by the PETER G. Peterson Foundation, US healthcare spending hit USD 4.5 trillion in 2022, or USD 13,493 per person, much more than in other wealthy countries. Due to such high healthcare costs, Americans are encouraged to spend money on nutraceutical ingredients and other preventive measures in order to maintain their health and lower their long-term medical costs.

A 2023 CRN Consumer Survey on Dietary Supplements stated that 74 percent of US adults take dietary supplements, with 55 percent among them taking them regularly. This simply indicates the importance of dietary supplements in promoting health in the nation. The desire for proactive health management in the face of rising healthcare costs and rising consumer awareness are the driving forces behind this widespread use. This growth is also supported by strong research and development activities and a very encouraging regulatory environment that allows innovation in health products. Businesses in the US are better able to develop and commercialize innovative nutraceutical ingredients because of their sophisticated infrastructure and highly qualified workforce.

The break-up of the profile of primary participants in the nutraceutical ingredients market:

  • By Company Type: Tier 1 - 51%, Tier 2 - 26%, and Tier 3 - 23%
  • By Designation: CXO's - 24%, Managers - 43%, Executives- 33%
  • By Region: North America - 25%, Europe - 20%, Asia Pacific - 45%, South America - 5%, and Rest of the World -5%

Prominent companies include Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark).

Research Coverage:

This research report categorizes the nutraceutical ingredients market by applications (food, beverages, animal nutrition, dietary supplements, and foods for special medical purposes (FSMP)), type (proteins, amino acids, fibers & specialty carbohydrates, probiotics, phytochemicals & plant extracts, prebiotics, functional fats & oils, vitamins, minerals, carotenoids, and other types), form (dry and liquid), function (qualitative), and region (North America, Europe, Asia Pacific, South America, and Rest of the World).

The report covers information about the key factors, such as drivers, restraints, opportunities, and challenges impacting the growth of the nutraceutical ingredients market. It also provides a detailed analysis of the major players in the market including their business overview, products offered; key strategies; partnerships, new product launches, expansions, and acquisitions. Competitive benchmarking of upcoming startups in the nutraceutical ingredients market is covered in this report.

Reasons to buy this report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall nutraceutical ingredients market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (Growing demand for fortified food due to increased health consciousness

among consumers), restraints (Higher costs of fortified products dissuade large-scale usage and adoption), opportunities (Nutraceuticals as alternatives for pharmaceuticals), and challenges (Combating counterfeiting in the nutraceutical industry) influencing the growth of the nutraceutical ingredients market.

  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the nutraceutical ingredients market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the nutraceutical ingredients market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the nutraceutical ingredients market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, and product offerings of leading players such as Cargill, Incorporated (US), ADM (US), International Flavors & Fragrances Inc. (US), BASF SE (Germany), Arla Foods amba (Denmark), Associated British Foods plc (UK), dsm-firmenich (Switzerland), Ingredion (US), Tate & Lyle (UK), Ajinomoto Co., Inc. (Japan), and Chr. Hansen A/S (Denmark) among others in the nutraceutical ingredients market strategies. The report also helps stakeholders understand the nutraceutical ingredients market and provides them with information on key market drivers, restraints, challenges, and opportunities.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 STUDY SCOPE
    • 1.3.1 MARKET SEGMENTATION
    • 1.3.2 INCLUSIONS & EXCLUSIONS
    • 1.3.3 YEARS CONSIDERED
  • 1.4 UNIT CONSIDERED
    • 1.4.1 CURRENCY CONSIDERED
    • 1.4.2 VOLUME UNIT CONSIDERED
  • 1.5 STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key insights from industry experts
      • 2.1.2.3 Breakdown of primary interviews
  • 2.2 MARKET SIZE ESTIMATION
    • 2.2.1 BOTTOM-UP APPROACH
    • 2.2.2 TOP-DOWN APPROACH
    • 2.2.3 SUPPLY-SIDE ANALYSIS
    • 2.2.4 DEMAND-SIDE ANALYSIS
  • 2.3 DATA TRIANGULATION
  • 2.4 RESEARCH ASSUMPTIONS
  • 2.5 LIMITATIONS AND RISK ASSESSMENT

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET
  • 4.2 ASIA PACIFIC NUTRACEUTICAL INGREDIENTS MARKET, BY KEY TYPE AND COUNTRY
  • 4.3 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL SNAPSHOT
  • 4.4 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE AND REGION
  • 4.5 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION AND REGION
  • 4.6 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM AND REGION

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MACROECONOMIC INDICATORS
    • 5.2.1 DEVELOPMENTS IN RETAIL INDUSTRY
    • 5.2.2 RISE IN NUMBER OF DUAL-INCOME HOUSEHOLDS
  • 5.3 MARKET DYNAMICS
    • 5.3.1 DRIVERS
      • 5.3.1.1 Growing demand for fortified food due to increased health consciousness
      • 5.3.1.2 Rising incidences of chronic diseases
      • 5.3.1.3 Mandates on food fortification by government organizations
      • 5.3.1.4 Rise in awareness about feed quality
      • 5.3.1.5 Increase in personalized nutrition trends
      • 5.3.1.6 Rise in digital health platforms and wearable & implantable technologies
    • 5.3.2 RESTRAINTS
      • 5.3.2.1 Higher costs of fortified products dissuade large-scale usage and adoption
    • 5.3.3 OPPORTUNITIES
      • 5.3.3.1 Rising use of nutraceuticals as alternatives for pharmaceuticals
      • 5.3.3.2 Alternative sources to obtain functional fats & oils
    • 5.3.4 CHALLENGES
      • 5.3.4.1 Proliferation of counterfeit products
      • 5.3.4.2 Lack of consistency in regulations pertaining to various ingredients

6 INDUSTRY TRENDS

  • 6.1 INTRODUCTION
  • 6.2 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • 6.3 PRICING ANALYSIS
    • 6.3.1 AVERAGE SELLING PRICE TREND, BY TYPE
    • 6.3.2 AVERAGE SELLING PRICE TREND, BY REGION
  • 6.4 VALUE CHAIN ANALYSIS
    • 6.4.1 RAW MATERIAL SOURCING
    • 6.4.2 PRODUCTION & PROCESSING
    • 6.4.3 DISTRIBUTION
    • 6.4.4 END USERS
  • 6.5 ECOSYSTEM
    • 6.5.1 DEMAND SIDE
      • 6.5.1.1 Ingredient manufacturers
      • 6.5.1.2 Technology providers
      • 6.5.1.3 Start-ups/emerging companies
    • 6.5.2 SUPPLY SIDE
      • 6.5.2.1 Regulatory bodies
      • 6.5.2.2 End users
  • 6.6 TECHNOLOGY ANALYSIS
    • 6.6.1 KEY TECHNOLOGIES
      • 6.6.1.1 CRISPR and gene editing
    • 6.6.2 COMPLEMENTARY TECHNOLOGIES
      • 6.6.2.1 Microencapsulated powder for probiotic action in food products
      • 6.6.2.2 Robotics leading to innovations in market
      • 6.6.2.3 Hologram sciences-platform for personalized nutrition and advice
    • 6.6.3 ADJACENT TECHNOLOGIES
      • 6.6.3.1 3D printing
  • 6.7 PATENT ANALYSIS
  • 6.8 TRADE ANALYSIS
    • 6.8.1 EXPORT SCENARIO OF NUTRACEUTICAL INGREDIENTS
      • 6.8.1.1 Import scenario of nutraceutical ingredients
  • 6.9 KEY CONFERENCES AND EVENTS, 2024-2025
  • 6.10 TARIFF AND REGULATORY LANDSCAPE
    • 6.10.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 6.10.2 REGULATORY FRAMEWORK
      • 6.10.2.1 Organizations/Regulations governing nutraceutical ingredients market
      • 6.10.2.2 North America
        • 6.10.2.2.1 Canada
        • 6.10.2.2.2 US
        • 6.10.2.2.3 Mexico
      • 6.10.2.3 European Union (EU)
      • 6.10.2.4 Asia Pacific
        • 6.10.2.4.1 Japan
        • 6.10.2.4.2 China
        • 6.10.2.4.3 India
        • 6.10.2.4.4 Australia & New Zealand
      • 6.10.2.5 Rest of the World (RoW)
        • 6.10.2.5.1 Brazil
      • 6.10.2.6 Probiotics
        • 6.10.2.6.1 Introduction
        • 6.10.2.6.2 National/International bodies for safety standards and regulations
        • 6.10.2.6.3 North America: Regulatory environment analysis
        • 6.10.2.6.4 Europe: Regulatory environment analysis
        • 6.10.2.6.5 Asia Pacific: Regulatory environment analysis
        • 6.10.2.6.6 South America: Regulatory environment analysis
      • 6.10.2.7 Prebiotics
        • 6.10.2.7.1 Introduction
        • 6.10.2.7.2 Asia Pacific
        • 6.10.2.7.3 North America
        • 6.10.2.7.4 European Union
  • 6.11 PORTER'S FIVE FORCES ANALYSIS
    • 6.11.1 INTENSITY OF COMPETITIVE RIVALRY
    • 6.11.2 THREAT OF NEW ENTRANTS
    • 6.11.3 THREAT OF SUBSTITUTES
    • 6.11.4 BARGAINING POWER OF SUPPLIERS
    • 6.11.5 BARGAINING POWER OF BUYERS
  • 6.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 6.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • 6.12.2 BUYING CRITERIA
  • 6.13 CASE STUDY ANALYSIS
    • 6.13.1 FRUNUTTA STARTED OFFERING EASY-TO-USE AND EFFICIENT-TO-TAKE VITAMIN AND MINERAL PILLS THAT DISSOLVE INSTANTLY
    • 6.13.2 MAGNITUDE BIOSCIENCES AND AB BIOTEK HNH EVALUATED PROBIOTIC DEVELOPMENT WITH ETHICAL AND HIGH-THROUGHPUT TESTING
    • 6.13.3 ROQUETTE FRERES ACHIEVED COMPLETE AMINO ACID PROFILE WITH NUTRALYS PEA PROTEIN
  • 6.14 INVESTMENT AND FUNDING SCENARIO
  • 6.15 IMPACT OF GEN AI ON FOOD & BEVERAGE INGREDIENTS/ADDITIVES
    • 6.15.1 USE OF GEN AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
    • 6.15.2 CASE STUDIES FOR GENERATIVE AI IN FOOD & BEVERAGE INGREDIENTS/ADDITIVES
      • 6.15.2.1 Flavor and ingredient innovation
      • 6.15.2.2 AI-enabled digital tools for consumer understanding and product development
      • 6.15.2.3 Personalized AI-developed nutrition platform
      • 6.15.2.4 AI and cloud technology to address challenges in F&B industry
    • 6.15.3 IMPACT OF GENERATIVE AI/AI ON NUTRACEUTICAL INGREDIENTS MARKET
    • 6.15.4 ADJACENT ECOSYSTEM WORKING ON GENERATIVE AI

7 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE

  • 7.1 INTRODUCTION
  • 7.2 PROTEINS
  • 7.3 AMINO ACIDS
    • 7.3.1 BRANCHED CHAIN AMINO ACIDS
      • 7.3.1.1 Leucine
      • 7.3.1.2 Isoleucine
      • 7.3.1.3 Valine
    • 7.3.2 LYSINE
    • 7.3.3 METHIONINE
    • 7.3.4 THREONINE
    • 7.3.5 TRYPTOPHAN
    • 7.3.6 GLUTAMIC ACID
    • 7.3.7 PHENYLALANINE
    • 7.3.8 OTHER AMINO ACID TYPES
  • 7.4 FIBERS & SPECIALTY CARBOHYDRATES
  • 7.5 PROBIOTICS
  • 7.6 PHYTOCHEMICALS & PLANT EXTRACTS
  • 7.7 PREBIOTICS
  • 7.8 FUNCTIONAL FATS & OILS
    • 7.8.1 POLYUNSATURATED FATTY ACIDS (PUFAS)
      • 7.8.1.1 Omega-3 fatty acids
      • 7.8.1.2 Omega-6 fatty acids
      • 7.8.1.3 Conjugated Linoleic Acid (CLA)
    • 7.8.2 OMEGA-9 FATTY ACIDS
    • 7.8.3 MEDIUM CHAIN TRIGLYCERIDES
    • 7.8.4 OTHER FUNCTIONAL FATS & OILS
  • 7.9 VITAMINS
    • 7.9.1 VITAMIN A
    • 7.9.2 VITAMIN B
    • 7.9.3 VITAMIN C
    • 7.9.4 VITAMIN D
    • 7.9.5 VITAMIN E
    • 7.9.6 VITAMIN K
  • 7.10 MINERALS
  • 7.11 CAROTENOIDS
    • 7.11.1 LUTEIN
    • 7.11.2 ASTAXANTHIN
    • 7.11.3 ZEAXANTHIN
    • 7.11.4 B-CAROTENE
    • 7.11.5 LYCOPENE
    • 7.11.6 OTHER CAROTENOIDS
  • 7.12 OTHER TYPES

8 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION

  • 8.1 INTRODUCTION
  • 8.2 FOOD
    • 8.2.1 TECHNOLOGICAL ADVANCEMENTS IN FOOD PROCESSING EQUIPMENT, HIGH HEALTHCARE COSTS, AND INCREASED INCIDENCES OF CHRONIC DISEASE TO DRIVE MARKET
    • 8.2.2 BAKERY & SNACKS
    • 8.2.3 CONFECTIONERY
    • 8.2.4 DAIRY
    • 8.2.5 MEAT & MEAT PRODUCTS
    • 8.2.6 BABY FOOD
    • 8.2.7 OTHER FOOD PRODUCTS
  • 8.3 BEVERAGES
    • 8.3.1 RISING HEALTH-CONSCIOUSNESS, HECTIC LIFESTYLES OF WORKING POPULATION, AND GROWING INCLINATION TOWARD HEALTHY BEVERAGES TO PROPEL MARKET
    • 8.3.2 ENERGY DRINKS
    • 8.3.3 JUICES
    • 8.3.4 HEALTH DRINKS
  • 8.4 ANIMAL NUTRITION
    • 8.4.1 INCREASE IN DEMAND FOR ANIMAL HEALTH AND NUTRITION TO FUEL DEMAND FOR NUTRACEUTICAL INGREDIENTS IN ANIMAL NUTRITION
    • 8.4.2 AMINO ACID IN ANIMAL NUTRITION
  • 8.5 DIETARY SUPPLEMENTS
    • 8.5.1 CONSUMER AWARENESS AND GROWING INCLINATION TOWARD INITIATIVE-TAKING HEALTH MANAGEMENT TO FOSTER MARKET GROWTH
  • 8.6 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP)
    • 8.6.1 ADVANCEMENTS IN MEDICAL RESEARCH, INCREASING AWARENESS ABOUT CLINICAL NUTRITION, AND CONTINUOUS EMERGENCE OF NEW MEDICAL CONDITIONS TO BOOST MARKET GROWTH

9 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM

  • 9.1 INTRODUCTION
  • 9.2 DRY
    • 9.2.1 SUPERIOR STABILITY, CONVENIENT HANDLING, AND LONGER SHELF-LIFE TO FUEL DEMAND FOR DRY FORM OF INGREDIENTS
  • 9.3 LIQUID
    • 9.3.1 EASE OF CONSUMPTION AND FASTER ABSORPTION RATES TO FOSTER DEMAND FOR LIQUID FORM OF INGREDIENTS

10 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTION

  • 10.1 INTRODUCTION
  • 10.2 ADDITIONAL SUPPLEMENTS
    • 10.2.1 NEED TO ADDRESS SPECIFIC DEFICIENCIES, MANAGE HEALTH CONDITIONS, AND ENHANCE PHYSICAL APPEARANCE TO BOOST MARKET GROWTH
    • 10.2.2 NUTRITION
    • 10.2.3 WEIGHT MANAGEMENT
    • 10.2.4 SKIN HEALTH
  • 10.3 MEDICINAL SUPPLEMENTS
    • 10.3.1 INCREASING CONSUMER AWARENESS ABOUT PREVENTIVE HEALTHCARE AND RISING INCIDENCES OF LIFESTYLE-RELATED DISEASES TO DRIVE MARKET
    • 10.3.2 GUT HEALTH
    • 10.3.3 HEART HEALTH
    • 10.3.4 BONE HEALTH
    • 10.3.5 IMMUNITY
    • 10.3.6 EYE HEALTH
    • 10.3.7 OTHER MEDICAL SUPPLEMENTS
  • 10.4 SPORTS NUTRITION
    • 10.4.1 INCREASED NUTRIENT REQUIREMENTS DUE TO DEMANDING PHYSICAL ACTIVITIES TO DRIVE DEMAND

11 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION

  • 11.1 INTRODUCTION
  • 11.2 NORTH AMERICA
    • 11.2.1 US
      • 11.2.1.1 Increased consumer demand for fortified food & beverages and rising healthcare costs to drive market
    • 11.2.2 CANADA
      • 11.2.2.1 High prevalence of inadequate vitamin D and calcium levels, rising food industry, and growing consumer health awareness to propel market
    • 11.2.3 MEXICO
      • 11.2.3.1 Rise in per capita expenditure on nutritious and healthy foods to fuel demand for nutraceutical ingredients
  • 11.3 EUROPE
    • 11.3.1 GERMANY
      • 11.3.1.1 Growing dietary supplement industry and focus on functional foods to address health concerns to boost market growth
    • 11.3.2 UK
      • 11.3.2.1 Rising awareness regarding healthy diet and increasing demand for dietary ingredients to drive market
    • 11.3.3 FRANCE
      • 11.3.3.1 Increased health awareness and strategic government initiatives to foster market
    • 11.3.4 ITALY
      • 11.3.4.1 High consumption of food supplements and functional foods, widespread acceptance of probiotic products, and rising awareness of associated health benefits to accelerate market growth
    • 11.3.5 SPAIN
      • 11.3.5.1 Increased pork production to drive market growth
    • 11.3.6 REST OF EUROPE
  • 11.4 ASIA PACIFIC
    • 11.4.1 CHINA
      • 11.4.1.1 Growing 'punk nutrition' trend coupled with changing lifestyles to progress market growth
    • 11.4.2 INDIA
      • 11.4.2.1 Emphasis on preventive healthcare due to rising hospitalization costs to foster market growth
    • 11.4.3 JAPAN
      • 11.4.3.1 Weather conditions being suitable for microbial growth and focus on fortified foods to boost market growth
    • 11.4.4 AUSTRALIA & NEW ZEALAND
      • 11.4.4.1 Changing lifestyles, increased purchasing power, and rising spending on nutritional foods to accelerate market growth
    • 11.4.5 REST OF ASIA PACIFIC
  • 11.5 SOUTH AMERICA
    • 11.5.1 BRAZIL
      • 11.5.1.1 Improved health consciousness, growing urbanization, health consciousness, and escalating obesity rates to propel market
    • 11.5.2 ARGENTINA
      • 11.5.2.1 Prevalence of malnutrition and need for nutritious diet to drive market growth
    • 11.5.3 REST OF SOUTH AMERICA
  • 11.6 REST OF THE WORLD (ROW)
    • 11.6.1 MIDDLE EAST
      • 11.6.1.1 Increased demand for healthy food amid rising health concerns to foster market growth
    • 11.6.2 AFRICA
      • 11.6.2.1 Government initiatives for fortification of food with essential vitamins and minerals to boost market growth

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 12.3 REVENUE ANALYSIS
  • 12.4 MARKET SHARE ANALYSIS, 2023
    • 12.4.1 MARKET RANKING ANALYSIS
  • 12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 12.5.1 STARS
    • 12.5.2 EMERGING LEADERS
    • 12.5.3 PERVASIVE PLAYERS
    • 12.5.4 PARTICIPANTS
    • 12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
      • 12.5.5.1 Company footprint
      • 12.5.5.2 Regional footprint
      • 12.5.5.3 Type footprint
      • 12.5.5.4 Application footprint
      • 12.5.5.5 Form footprint
  • 12.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2023
    • 12.6.1 PROGRESSIVE COMPANIES
    • 12.6.2 RESPONSIVE COMPANIES
    • 12.6.3 DYNAMIC COMPANIES
    • 12.6.4 STARTING BLOCKS
    • 12.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2023
      • 12.6.5.1 Key start-ups/SMEs
      • 12.6.5.2 Competitive benchmarking of key start-ups/SMEs
  • 12.7 COMPANY VALUATION AND FINANCIAL METRICS
  • 12.8 BRAND/PRODUCT COMPARISON
  • 12.9 COMPETITIVE SCENARIO AND TRENDS
    • 12.9.1 PRODUCT LAUNCHES AND ENHANCEMENTS
    • 12.9.2 DEALS
    • 12.9.3 EXPANSIONS
    • 12.9.4 OTHER DEALS/DEVELOPMENTS

13 COMPANY PROFILES

  • 13.1 KEY PLAYERS
    • 13.1.1 CARGILL, INCORPORATED
      • 13.1.1.1 Business overview
      • 13.1.1.2 Products/Solutions/Services offered
      • 13.1.1.3 Recent developments
        • 13.1.1.3.1 Deals
        • 13.1.1.3.2 Other deals/developments
      • 13.1.1.4 MnM view
        • 13.1.1.4.1 Right to win
        • 13.1.1.4.2 Strategic choices made
        • 13.1.1.4.3 Weaknesses and competitive threats
    • 13.1.2 ADM
      • 13.1.2.1 Business overview
      • 13.1.2.2 Products/Solutions/Services offered
      • 13.1.2.3 Recent developments
        • 13.1.2.3.1 Product launches
        • 13.1.2.3.2 Deals
        • 13.1.2.3.3 Other deals/developments
      • 13.1.2.4 MnM view
        • 13.1.2.4.1 Right to win
        • 13.1.2.4.2 Strategic choices made
        • 13.1.2.4.3 Weaknesses and competitive threats
    • 13.1.3 INTERNATIONAL FLAVORS & FRAGRANCES INC.
      • 13.1.3.1 Business overview
      • 13.1.3.2 Products/Solutions/Services offered
      • 13.1.3.3 Recent developments
        • 13.1.3.3.1 Product launches
        • 13.1.3.3.2 Deals
        • 13.1.3.3.3 Other deals/developments
      • 13.1.3.4 MnM view
        • 13.1.3.4.1 Right to win
        • 13.1.3.4.2 Strategic choices made
        • 13.1.3.4.3 Weaknesses and competitive threats
    • 13.1.4 BASF SE
      • 13.1.4.1 Business overview
      • 13.1.4.2 Products/Solutions/Services offered
      • 13.1.4.3 Recent developments
        • 13.1.4.3.1 Product launches and enhancements
        • 13.1.4.3.2 Deals
        • 13.1.4.3.3 Other deals/developments
      • 13.1.4.4 MnM view
        • 13.1.4.4.1 Right to win
        • 13.1.4.4.2 Strategic choices made
        • 13.1.4.4.3 Weaknesses and competitive threats
    • 13.1.5 ARLA FOODS AMBA
      • 13.1.5.1 Business overview
      • 13.1.5.2 Products/Solutions/Services offered
      • 13.1.5.3 Recent developments
        • 13.1.5.3.1 Product launches
        • 13.1.5.3.2 Deals
        • 13.1.5.3.3 Other deals/developments
      • 13.1.5.4 MnM view
        • 13.1.5.4.1 Right to win
        • 13.1.5.4.2 Strategic choices made
        • 13.1.5.4.3 Weaknesses and competitive threats
    • 13.1.6 DSM-FIRMENICH
      • 13.1.6.1 Business overview
      • 13.1.6.2 Products/Solutions/Services offered
      • 13.1.6.3 Recent developments
        • 13.1.6.3.1 Product launches
        • 13.1.6.3.2 Deals
      • 13.1.6.4 MnM view
    • 13.1.7 INGREDION
      • 13.1.7.1 Business overview
      • 13.1.7.2 Products/Solutions/Services offered
      • 13.1.7.3 Recent developments
        • 13.1.7.3.1 Product launches
        • 13.1.7.3.2 Deals
        • 13.1.7.3.3 Other deals/developments
      • 13.1.7.4 MnM view
    • 13.1.8 TATE & LYLE
      • 13.1.8.1 Business overview
      • 13.1.8.2 Products/Solutions/Services offered
      • 13.1.8.3 Recent developments
        • 13.1.8.3.1 Product launches
        • 13.1.8.3.2 Deals
        • 13.1.8.3.3 Other deals/developments
      • 13.1.8.4 MnM view
    • 13.1.9 AJINOMOTO CO., INC.
      • 13.1.9.1 Business overview
      • 13.1.9.2 Products/Solutions/Services offered
      • 13.1.9.3 Recent developments
        • 13.1.9.3.1 Deals
        • 13.1.9.3.2 Other deals/developments
      • 13.1.9.4 MnM view
    • 13.1.10 ASSOCIATED BRITISH FOODS PLC
      • 13.1.10.1 Business overview
      • 13.1.10.2 Products/Solutions/Services offered
      • 13.1.10.3 Recent developments
        • 13.1.10.3.1 Deals
      • 13.1.10.4 MnM view
    • 13.1.11 CHR. HANSEN A/S
      • 13.1.11.1 Business overview
      • 13.1.11.2 Products/Solutions/Services offered
      • 13.1.11.3 Recent developments
        • 13.1.11.3.1 Product launches and enhancements
        • 13.1.11.3.2 Deals
        • 13.1.11.3.3 Other deals/developments
      • 13.1.11.4 MnM view
    • 13.1.12 KYOWA KIRIN CO., LTD
      • 13.1.12.1 Business overview
      • 13.1.12.2 Products/Solutions/Services offered
      • 13.1.12.3 Recent developments
      • 13.1.12.4 MnM view
    • 13.1.13 GLANBIA PLC
      • 13.1.13.1 Business overview
      • 13.1.13.2 Products/Solutions/Services offered
      • 13.1.13.3 Recent developments
        • 13.1.13.3.1 Product launches
        • 13.1.13.3.2 Deals
        • 13.1.13.3.3 Other deals/developments
      • 13.1.13.4 MnM view
    • 13.1.14 FONTERRA CO-OPERATIVE GROUP LIMITED
      • 13.1.14.1 Business overview
      • 13.1.14.2 Products/Solutions/Services offered
      • 13.1.14.3 Recent developments
        • 13.1.14.3.1 Deals
      • 13.1.14.4 MnM view
    • 13.1.15 KERRY GROUP PLC
      • 13.1.15.1 Business overview
      • 13.1.15.2 Products/Solutions/Services offered
      • 13.1.15.3 Recent developments
        • 13.1.15.3.1 Product launches
        • 13.1.15.3.2 Deals
        • 13.1.15.3.3 Other deals/developments
      • 13.1.15.4 MnM view
  • 13.2 OTHER PLAYERS
    • 13.2.1 DIVI'S LABORATORIES LIMITED
      • 13.2.1.1 Business overview
      • 13.2.1.2 Products/Solutions/Services offered
      • 13.2.1.3 Recent developments
        • 13.2.1.3.1 Product launches
      • 13.2.1.4 MnM view
    • 13.2.2 ROQUETTE FRERES
      • 13.2.2.1 Business overview
      • 13.2.2.2 Products/Solutions/Services offered
      • 13.2.2.3 Recent developments
        • 13.2.2.3.1 Product launches and enhancements
        • 13.2.2.3.2 Other deals/developments
      • 13.2.2.4 MnM view
    • 13.2.3 BENEO
      • 13.2.3.1 Business overview
      • 13.2.3.2 Products/Solutions/Services offered
      • 13.2.3.3 Recent developments
        • 13.2.3.3.1 Other deals/developments
      • 13.2.3.4 MnM view
    • 13.2.4 KEMIN INDUSTRIES, INC.
      • 13.2.4.1 Business overview
      • 13.2.4.2 Products/Solutions/Services offered
      • 13.2.4.3 Recent developments
        • 13.2.4.3.1 Product enhancements
        • 13.2.4.3.2 Other deals/developments
      • 13.2.4.4 MnM view
    • 13.2.5 GOLDEN GRAIN GROUP LIMITED
      • 13.2.5.1 Business overview
      • 13.2.5.2 Products/Solutions/Services offered
      • 13.2.5.3 Recent developments
      • 13.2.5.4 MnM view
    • 13.2.6 COSUCRA
    • 13.2.7 PURIS
    • 13.2.8 PROEON
    • 13.2.9 CONAGEN, INC.
    • 13.2.10 CHICKP

14 ADJACENT & RELATED MARKETS

  • 14.1 INTRODUCTION
  • 14.2 RESEARCH LIMITATIONS
  • 14.3 DIETARY SUPPLEMENTS MARKET
    • 14.3.1 MARKET DEFINITION
    • 14.3.2 MARKET OVERVIEW
    • 14.3.3 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER
    • 14.3.4 DIETARY SUPPLEMENTS MARKET, BY REGION
  • 14.4 HEALTH INGREDIENTS MARKET
    • 14.4.1 MARKET DEFINITION
    • 14.4.2 MARKET OVERVIEW
    • 14.4.3 HEALTH INGREDIENTS MARKET, BY SOURCE
    • 14.4.4 HEALTH INGREDIENTS MARKET, BY REGION

15 APPENDIX

  • 15.1 DISCUSSION GUIDE
  • 15.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 15.3 CUSTOMIZATION OPTIONS
  • 15.4 RELATED REPORTS
  • 15.5 AUTHOR DETAILS

List of Tables

  • TABLE 1 USD EXCHANGE RATES, 2020-2023
  • TABLE 2 NUTRACEUTICAL INGREDIENTS MARKET SHARE SNAPSHOT, 2024 VS. 2029 (USD MILLION)
  • TABLE 3 GLOBAL PREVALENCE OF ANEMIA ACROSS DIFFERENT POPULATION GROUPS, 2019
  • TABLE 4 WIDELY USED FORTIFIED FOODS
  • TABLE 5 PERSONALIZED NUTRITION TRENDS AND ADVANCEMENTS
  • TABLE 6 EXAMPLES OF UNITED STATES FDA-APPROVED MEDICAL WEARABLE AND IMPLANTABLE DEVICES
  • TABLE 7 HEALTH ISSUES AND NUTRACEUTICAL INGREDIENTS USED FOR CURE
  • TABLE 8 UPCOMING ALTERNATIVE SOURCES FOR OMEGA-3 FATTY ACIDS
  • TABLE 9 AVERAGE SELLING PRICES OF TOP THREE TYPES, 2020-2023 (USD/KG)
  • TABLE 10 AVERAGE SELLING PRICE TRENDS, BY REGION, 2020-2023 (USD/KG)
  • TABLE 11 NUTRACEUTICAL INGREDIENTS MARKET: ECOSYSTEM
  • TABLE 12 LIST OF MAJOR PATENTS PERTAINING TO NUTRACEUTICAL INGREDIENTS MARKET, 2014-2024
  • TABLE 13 TOP FIVE EXPORTERS OF NUTRACEUTICAL INGREDIENTS (HS CODE 2936), 2023 (USD THOUSAND)
  • TABLE 14 TOP FIVE IMPORTERS OF NUTRACEUTICAL INGREDIENTS (HS CODE 2936), 2023 (USD THOUSAND)
  • TABLE 15 NUTRACEUTICAL INGREDIENTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024-2025
  • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 17 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 18 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 19 SOUTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 20 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • TABLE 21 DEFINITIONS AND REGULATIONS FOR NUTRACEUTICAL INGREDIENTS WORLDWIDE
  • TABLE 22 REGULATORY ORGANIZATIONS FOR NUTRACEUTICALS INGREDIENTS WORLDWIDE
  • TABLE 23 SCHEDULE - XI OF FOOD SAFETY AND STANDARDS REGULATIONS FOR LIST OF APPROVED PREBIOTIC INGREDIENTS, 2015
  • TABLE 24 LIST OF ACCEPTED DIETARY FIBERS BY CANADIAN REGULATORY AUTHORITIES AND THEIR SOURCES
  • TABLE 25 PORTER'S FIVE FORCES IMPACT ON NUTRACEUTICAL INGREDIENTS MARKET
  • TABLE 26 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES
  • TABLE 27 KEY BUYING CRITERIA FOR TOP THREE TYPES
  • TABLE 28 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 29 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 30 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (KILO TON)
  • TABLE 31 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (KILO TON)
  • TABLE 32 RECOMMENDED DIETARY ALLOWANCES (RDA) FOR PROTEINS IN DIFFERENT AGE GROUPS (GRAMS/DAY)
  • TABLE 33 FUNCTIONS OF PROTEIN
  • TABLE 34 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 35 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 36 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 37 PROTEINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 38 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 39 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 40 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 41 AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 43 NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 44 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 45 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 46 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2020-2023 (USD MILLION)
  • TABLE 47 BRANCHED CHAIN AMINO ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2024-2029 (USD MILLION)
  • TABLE 48 LEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 49 LEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 50 ISOLEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 51 ISOLEUCINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 52 VALINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 53 VALINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 54 LYSINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 55 LYSINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 56 METHIONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 57 METHIONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 58 THREONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 59 THREONINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 60 TRYPTOPHAN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 61 TRYPTOPHAN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 62 GLUTAMIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 63 GLUTAMIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 64 PHENYLALANINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 65 PHENYLALANINE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 66 OTHER AMINO ACID TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 67 OTHER AMINO ACID TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 68 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 69 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 70 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 71 FIBERS & SPECIALTY CARBOHYDRATES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 72 PROBIOTIC COMPONENTS & THEIR BENEFITS
  • TABLE 73 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 74 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 75 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 76 PROBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 77 SPECIFIC PHYTOCHEMICALS AND THEIR POTENTIAL BENEFITS
  • TABLE 78 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 79 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 80 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 81 PHYTOCHEMICALS & PLANT EXTRACTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 82 PREBIOTIC COMPONENTS & THEIR BENEFITS
  • TABLE 83 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 84 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 85 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 86 PREBIOTICS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 87 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 88 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 89 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 90 FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 91 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 92 NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 93 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 94 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 95 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2020-2023 (USD MILLION)
  • TABLE 96 POLYUNSATURATED FATTY ACIDS (PUFAS): NUTRACEUTICAL INGREDIENTS MARKET, BY SUB-TYPE, 2024-2029 (USD MILLION)
  • TABLE 97 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 98 OMEGA-3 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 99 OMEGA-6 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 100 OMEGA-6 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 101 CONJUGATED LINOLEIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 102 CONJUGATED LINOLEIC ACID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 103 OMEGA-9 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 104 OMEGA-9 FATTY ACIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 105 MEDIUM CHAIN TRIGLYCERIDES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 106 MEDIUM CHAIN TRIGLYCERIDES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 107 OTHER FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 108 OTHER FUNCTIONAL FATS & OILS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 109 VITAMINS CLASSIFIED AS MICRONUTRIENTS
  • TABLE 110 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 111 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 112 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 113 VITAMINS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 114 NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 115 NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 116 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 117 VITAMIN A: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 118 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 119 VITAMIN B: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 120 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 121 VITAMIN C: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 122 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 123 VITAMIN D: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 124 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 125 VITAMIN E: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 126 VITAMIN K: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 127 VITAMIN K: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 128 MACROMINERALS & THEIR FUNCTIONS
  • TABLE 129 MICROMINERALS & THEIR FUNCTIONS
  • TABLE 130 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 131 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 132 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 133 MINERALS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 134 SOURCES OF CAROTENOIDS IN FRUITS AND VEGETABLES AND THEIR MEDICINAL PROPERTIES
  • TABLE 135 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 136 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 137 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 138 CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 139 NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 140 NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 141 LUTEIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 142 LUTEIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 143 ASTAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 144 ASTAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 145 ZEAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 146 ZEAXANTHIN: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 147 B-CAROTENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 148 B-CAROTENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 149 LYCOPENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 150 LYCOPENE: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 151 OTHER CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 152 OTHER CAROTENOIDS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 153 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 154 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 155 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 156 OTHER TYPES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 157 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 158 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 159 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 160 FOOD: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 161 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MACRONUTRIENTS
  • TABLE 162 RECOMMENDED DIETARY REFERENCE INTAKES (DRIS) FOR MICRONUTRIENTS
  • TABLE 163 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 164 BEVERAGES: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 165 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 166 ANIMAL NUTRITION: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 167 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 168 DIETARY SUPPLEMENTS: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 169 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 170 FOOD FOR SPECIAL MEDICAL PURPOSES (FSMP): NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 171 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020-2023 (USD MILLION)
  • TABLE 172 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024-2029 (USD MILLION)
  • TABLE 173 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 174 DRY: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 175 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 176 LIQUID: NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 177 BONE-BUILDING NUTRIENTS & THEIR THERAPEUTIC RANGE
  • TABLE 178 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (USD MILLION)
  • TABLE 179 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (USD MILLION)
  • TABLE 180 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2020-2023 (KILO TON)
  • TABLE 181 NUTRACEUTICAL INGREDIENTS MARKET, BY REGION, 2024-2029 (KILO TON)
  • TABLE 182 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 183 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 184 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 185 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 186 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (KILO TON)
  • TABLE 187 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (KILO TON)
  • TABLE 188 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 189 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 190 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 191 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 192 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 193 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 194 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 195 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 196 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 197 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 198 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 199 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 200 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 201 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 202 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020-2023 (USD MILLION)
  • TABLE 203 NORTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024-2029 (USD MILLION)
  • TABLE 204 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 205 US: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 206 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 207 US: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 208 US: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 209 US: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 210 US: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 211 US: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 212 US: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 213 US: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 214 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 215 US: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 216 US: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 217 US: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 218 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 219 US: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 220 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 221 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 222 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 223 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 224 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 225 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 226 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 227 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 228 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 229 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 230 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 231 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 232 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 233 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 234 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 235 CANADA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 236 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 237 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 238 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 239 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 240 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 241 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 242 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 243 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 244 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 245 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 246 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 247 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 248 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 249 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 250 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 251 MEXICO: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 252 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020-2023 (USD MILLION)
  • TABLE 253 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024-2029 (USD MILLION)
  • TABLE 254 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 255 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 256 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (KILO TON)
  • TABLE 257 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (KILO TON)
  • TABLE 258 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 259 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 260 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 261 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 262 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 263 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 264 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 265 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 266 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 267 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 268 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 269 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 270 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 271 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 272 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020-2023 (USD MILLION)
  • TABLE 273 EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024-2029 (USD MILLION)
  • TABLE 274 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 275 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 276 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 277 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 278 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 279 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 280 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 281 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 282 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 283 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 284 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 285 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 286 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 287 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 288 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 289 GERMANY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 290 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 291 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 292 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 293 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 294 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 295 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 296 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 297 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 298 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 299 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 300 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 301 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 302 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 303 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 304 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 305 UK: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 306 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 307 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 308 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 309 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 310 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 311 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 312 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 313 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 314 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 315 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 316 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 317 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 318 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 319 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024-2029 (USD MILLION)
  • TABLE 320 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020-2023 (USD MILLION)
  • TABLE 321 FRANCE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024-2029 (USD MILLION)
  • TABLE 322 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020-2023 (USD MILLION)
  • TABLE 323 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024-2029 (USD MILLION)
  • TABLE 324 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 325 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 326 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020-2023 (USD MILLION)
  • TABLE 327 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024-2029 (USD MILLION)
  • TABLE 328 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020-2023 (USD MILLION)
  • TABLE 329 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024-2029 (USD MILLION)
  • TABLE 330 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020-2023 (USD MILLION)
  • TABLE 331 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024-2029 (USD MILLION)
  • TABLE 332 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020-2023 (USD MILLION)
  • TABLE 333 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024-2029 (USD MILLION)
  • TABLE 334 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020-2023 (USD MILLION)
  • TABLE 335 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 336 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 337 ITALY: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION,2024–2029 (USD MILLION)
  • TABLE 338 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 339 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 340 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 341 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE,2024–2029 (USD MILLION)
  • TABLE 342 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 343 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 344 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 345 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 346 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 347 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 348 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 349 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 350 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 351 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 352 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 353 SPAIN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 354 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 355 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 356 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 357 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 358 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 359 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 360 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 361 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 362 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 363 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 364 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 365 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 366 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 367 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 368 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 369 REST OF EUROPE: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 370 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 371 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 372 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 373 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 374 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON)
  • TABLE 375 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON)
  • TABLE 376 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 377 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 378 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 379 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 380 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 381 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 382 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 383 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 384 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 385 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 386 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 387 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 388 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 389 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 390 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION)
  • TABLE 391 ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION)
  • TABLE 392 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 393 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE,2024–2029 (USD MILLION)
  • TABLE 394 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 395 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 396 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 397 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 398 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 399 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 400 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 401 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 402 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 403 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 404 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 405 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 406 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 407 CHINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 408 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 409 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 410 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 411 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 412 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 413 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 414 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 415 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 416 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 417 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 418 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 419 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 420 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 421 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 422 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 423 INDIA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 424 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 425 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 426 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 427 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 428 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 429 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 430 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 431 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 432 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 433 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 434 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 435 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 436 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 437 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 438 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 439 JAPAN: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 440 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 441 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 442 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 443 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 444 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 445 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 446 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 447 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 448 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 449 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 450 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 451 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 452 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 453 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 454 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 455 AUSTRALIA & NEW ZEALAND: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 456 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 457 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 458 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 459 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 460 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 461 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 462 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 463 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 464 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 465 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 466 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 467 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 468 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 469 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 470 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 471 REST OF ASIA PACIFIC: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 472 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2020–2023 (USD MILLION)
  • TABLE 473 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY COUNTRY, 2024–2029 (USD MILLION)
  • TABLE 474 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 475 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 476 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON)
  • TABLE 477 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON)
  • TABLE 478 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 479 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 480 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 481 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 482 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 483 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 484 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 485 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 486 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 487 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 488 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 489 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 490 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 491 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 492 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION)
  • TABLE 493 SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION)
  • TABLE 494 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 495 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 496 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 497 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 498 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 499 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 500 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 501 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 502 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 503 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 504 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 505 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 506 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 507 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 508 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 509 BRAZIL: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 510 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 511 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 512 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 513 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 514 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 515 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 516 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 517 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 518 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 519 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 520 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 521 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 522 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 523 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 524 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 525 ARGENTINA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 526 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 527 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 528 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 529 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 530 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 531 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 532 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 533 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 534 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 535 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 536 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 537 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 538 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 539 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 540 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 541 REST OF SOUTH AMERICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 542 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBREGION, 2020–2023 (USD MILLION)
  • TABLE 543 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY SUBREGION, 2024–2029 (USD MILLION)
  • TABLE 544 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 545 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 546 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (KILO TON)
  • TABLE 547 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (KILO TON)
  • TABLE 548 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 549 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 550 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 551 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 552 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 553 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 554 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 555 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 556 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 557 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 558 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 559 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 560 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 561 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 562 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2020–2023 (USD MILLION)
  • TABLE 563 REST OF THE WORLD: NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024–2029 (USD MILLION)
  • TABLE 564 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 565 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 566 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 567 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 568 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 569 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 570 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 571 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 572 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 573 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 574 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 575 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 576 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 577 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 578 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 579 MIDDLE EAST: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 580 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2020–2023 (USD MILLION)
  • TABLE 581 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024–2029 (USD MILLION)
  • TABLE 582 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 583 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 584 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2020–2023 (USD MILLION)
  • TABLE 585 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY BRANCHED CHAIN AMINO ACID TYPE, 2024–2029 (USD MILLION)
  • TABLE 586 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2020–2023 (USD MILLION)
  • TABLE 587 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY FUNCTIONAL FATS & OILS TYPE, 2024–2029 (USD MILLION)
  • TABLE 588 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2020–2023 (USD MILLION)
  • TABLE 589 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY POLYUNSATURATED FATTY ACIDS (PUFAS) TYPE, 2024–2029 (USD MILLION)
  • TABLE 590 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2020–2023 (USD MILLION)
  • TABLE 591 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY VITAMIN TYPE, 2024–2029 (USD MILLION)
  • TABLE 592 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2020–2023 (USD MILLION)
  • TABLE 593 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY CAROTENOID TYPE, 2024–2029 (USD MILLION)
  • TABLE 594 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2020–2023 (USD MILLION)
  • TABLE 595 AFRICA: NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024–2029 (USD MILLION)
  • TABLE 596 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS VENDORS
  • TABLE 597 NUTRACEUTICAL INGREDIENTS MARKET: DEGREE OF COMPETITION
  • TABLE 598 NUTRACEUTICAL INGREDIENTS MARKET: REGIONAL FOOTPRINT
  • TABLE 599 NUTRACEUTICAL INGREDIENTS MARKET: TYPE FOOTPRINT
  • TABLE 600 NUTRACEUTICAL INGREDIENTS MARKET: APPLICATION FOOTPRINT
  • TABLE 601 NUTRACEUTICAL INGREDIENTS MARKET: FORM FOOTPRINT
  • TABLE 602 NUTRACEUTICAL INGREDIENTS MARKET: KEY START-UPS/SMES
  • TABLE 603 NUTRACEUTICAL INGREDIENTS MARKET: COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES, 2023
  • TABLE 604 NUTRACEUTICAL INGREDIENTS MARKET: PRODUCT LAUNCHES AND ENHANCEMENTS, MARCH 2020–MAY 2024
  • TABLE 605 NUTRACEUTICAL INGREDIENTS MARKET: DEALS, JANUARY 2020–JUNE 2024
  • TABLE 606 NUTRACEUTICAL INGREDIENTS MARKET: EXPANSIONS, MARCH 2020–MAY 2024
  • TABLE 607 NUTRACEUTICAL INGREDIENTS MARKET: OTHER DEALS/DEVELOPMENTS, JANUARY 2021–JANUARY 2024
  • TABLE 608 CARGILL, INCORPORATED: COMPANY OVERVIEW
  • TABLE 609 CARGILL, INCORPORATED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 610 CARGILL, INCORPORATED: DEALS
  • TABLE 611 CARGILL, INCORPORATED: EXPANSIONS
  • TABLE 612 CARGILL, INCORPORATED: OTHER DEALS/DEVELOPMENTS
  • TABLE 613 ADM: COMPANY OVERVIEW
  • TABLE 614 ADM: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 615 ADM: PRODUCT LAUNCHES
  • TABLE 616 ADM: DEALS
  • TABLE 617 ADM: EXPANSIONS
  • TABLE 618 ADM: OTHER DEALS/DEVELOPMENTS
  • TABLE 619 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY OVERVIEW
  • TABLE 620 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 621 INTERNATIONAL FLAVORS & FRAGRANCES INC.: PRODUCT LAUNCHES
  • TABLE 622 INTERNATIONAL FLAVORS & FRAGRANCES INC.: DEALS
  • TABLE 623 INTERNATIONAL FLAVORS & FRAGRANCES INC.: EXPANSIONS
  • TABLE 624 BASF SE: COMPANY OVERVIEW
  • TABLE 625 BASF SE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 626 BASF SE: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 627 BASF SE: DEALS
  • TABLE 628 BASF SE: EXPANSIONS
  • TABLE 629 BASF SE: OTHER DEALS/DEVELOPMENTS
  • TABLE 630 ARLA FOODS AMBA: COMPANY OVERVIEW
  • TABLE 631 ARLA FOODS AMBA: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 632 ARLA FOODS AMBA: PRODUCT LAUNCHES
  • TABLE 633 ARLA FOODS AMBA: DEALS
  • TABLE 634 ARLA FOODS AMBA: EXPANSIONS
  • TABLE 635 DSM-FIRMENICH: COMPANY OVERVIEW
  • TABLE 636 DSM-FIRMENICH: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 637 DSM-FIRMENICH: PRODUCT LAUNCHES
  • TABLE 638 DSM-FIRMENICH: DEALS
  • TABLE 639 INGREDION: COMPANY OVERVIEW
  • TABLE 640 INGREDION: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 641 INGREDION: PRODUCT LAUNCHES
  • TABLE 642 INGREDION: DEALS
  • TABLE 643 INGREDION: EXPANSIONS
  • TABLE 644 TATE & LYLE: COMPANY OVERVIEW
  • TABLE 645 TATE & LYLE: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 646 TATE & LYLE: PRODUCT LAUNCHES
  • TABLE 647 TATE & LYLE: DEALS
  • TABLE 648 TATE & LYLE: EXPANSIONS
  • TABLE 649 AJINOMOTO CO., INC.: COMPANY OVERVIEW
  • TABLE 650 AJINOMOTO CO., INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 651 AJINOMOTO CO., INC.: DEALS
  • TABLE 652 AJINOMOTO CO., INC.: EXPANSIONS
  • TABLE 653 ASSOCIATED BRITISH FOODS PLC: COMPANY OVERVIEW
  • TABLE 654 ASSOCIATED BRITISH FOODS PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 655 ASSOCIATED BRITISH FOODS PLC: DEALS
  • TABLE 656 CHR. HANSEN A/S: COMPANY OVERVIEW
  • TABLE 657 CHR. HANSEN A/S: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 658 CHR. HANSEN A/S: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 659 CHR. HANSEN A/S: DEALS
  • TABLE 660 CHR. HANSEN A/S: EXPANSIONS
  • TABLE 661 KYOWA KIRIN CO., LTD: COMPANY OVERVIEW
  • TABLE 662 KYOWA KIRIN CO., LTD: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 663 GLANBIA PLC: COMPANY OVERVIEW
  • TABLE 664 GLANBIA PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 665 GLANBIA PLC: PRODUCT LAUNCHES
  • TABLE 666 GLANBIA PLC: DEALS
  • TABLE 667 GLANBIA PLC: EXPANSIONS
  • TABLE 668 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY OVERVIEW
  • TABLE 669 FONTERRA CO-OPERATIVE GROUP LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 670 FONTERRA CO-OPERATIVE GROUP LIMITED: DEALS
  • TABLE 671 KERRY GROUP PLC: COMPANY OVERVIEW
  • TABLE 672 KERRY GROUP PLC: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 673 KERRY GROUP PLC: PRODUCT LAUNCHES
  • TABLE 674 KERRY GROUP PLC: DEALS
  • TABLE 675 KERRY GROUP PLC: EXPANSIONS
  • TABLE 676 DIVI'S LABORATORIES LIMITED: COMPANY OVERVIEW
  • TABLE 677 DIVI'S LABORATORIES LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 678 DIVI'S LABORATORIES LIMITED: PRODUCT LAUNCHES
  • TABLE 679 ROQUETTE FRÈRES: COMPANY OVERVIEW
  • TABLE 680 ROQUETTE FRÈRES: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 681 ROQUETTE FRÈRES: PRODUCT LAUNCHES AND ENHANCEMENTS
  • TABLE 682 ROQUETTE FRÈRES: EXPANSIONS
  • TABLE 683 BENEO: COMPANY OVERVIEW
  • TABLE 684 BENEO: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 685 BENEO: EXPANSIONS
  • TABLE 686 KEMIN INDUSTRIES, INC.: COMPANY OVERVIEW
  • TABLE 687 KEMIN INDUSTRIES, INC.: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 688 KEMIN INDUSTRIES, INC.: PRODUCT ENHANCEMENTS
  • TABLE 689 KEMIN INDUSTRIES, INC.: EXPANSIONS
  • TABLE 690 GOLDEN GRAIN GROUP LIMITED: COMPANY OVERVIEW
  • TABLE 691 GOLDEN GRAIN GROUP LIMITED: PRODUCTS/SOLUTIONS/SERVICES OFFERED
  • TABLE 692 COSUCRA: COMPANY OVERVIEW
  • TABLE 693 PURIS: COMPANY OVERVIEW
  • TABLE 694 PROEON: COMPANY OVERVIEW
  • TABLE 695 CONAGEN, INC.: COMPANY OVERVIEW
  • TABLE 696 CHICKP: COMPANY OVERVIEW
  • TABLE 697 ADJACENT MARKETS TO NUTRACEUTICAL INGREDIENTS MARKET
  • TABLE 698 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER, 2018–2022 (USD MILLION)
  • TABLE 699 DIETARY SUPPLEMENTS MARKET, BY TARGET CONSUMER, 2023–2028 (USD MILLION)
  • TABLE 700 DIETARY SUPPLEMENTS MARKET, BY REGION, 2018–2022 (USD MILLION)
  • TABLE 701 DIETARY SUPPLEMENTS MARKET, BY REGION, 2023–2028 (USD MILLION)
  • TABLE 702 HEALTH INGREDIENTS MARKET, BY SOURCE, 2017–2021 (USD MILLION)
  • TABLE 703 HEALTH INGREDIENTS MARKET, BY SOURCE, 2022–2027 (USD MILLION)
  • TABLE 704 HEALTH INGREDIENTS MARKET, BY REGION, 2017–2021 (USD MILLION)
  • TABLE 705 HEALTH INGREDIENTS MARKET, BY REGION, 2022–2027 (USD MILLION)

List of Figures

  • FIGURE 1 NUTRACEUTICAL INGREDIENTS MARKET: RESEARCH DESIGN
  • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS, BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 3 NUTRACEUTICAL INGREDIENTS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 5 SUPPLY-SIDE ANALYSIS
  • FIGURE 6 DEMAND-SIDE ANALYSIS
  • FIGURE 7 DATA TRIANGULATION
  • FIGURE 8 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 9 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 10 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024 VS. 2029 (USD MILLION)
  • FIGURE 11 NUTRACEUTICAL INGREDIENTS MARKET SHARE AND GROWTH RATE, BY REGION
  • FIGURE 12 ADVANCES IN FOOD SCIENCE AND TECHNOLOGY AND RISING DEMAND FOR CONVENIENCE AND HEALTHY FOOD PRODUCTS TO DRIVE MARKET
  • FIGURE 13 PROTEINS SEGMENT AND CHINA TO ACCOUNT FOR SIGNIFICANT SHARES IN 2024
  • FIGURE 14 US TO ACCOUNT FOR LARGEST MARKET SHARE IN 2024
  • FIGURE 15 PROTEINS SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
  • FIGURE 16 FOOD SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
  • FIGURE 17 DRY SEGMENT AND NORTH AMERICA TO ACCOUNT FOR LARGEST MARKET DURING FORECAST PERIOD
  • FIGURE 18 INDIA: FOOD & GROCERY IN RETAIL INDUSTRY, 2023 (USD BILLION)
  • FIGURE 19 US: EMPLOYMENT STATUS OF PARENTS WITH OWN CHILDREN UNDER 18 YEARS, 2021 VS. 2022
  • FIGURE 20 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: NUTRACEUTICAL INGREDIENTS MARKET
  • FIGURE 21 CONSUMERS' PERCEPTION REGARDING WHAT TO CONSUME OR AVOID
  • FIGURE 22 CHRONIC DISEASES BEING ONE OF TOP TEN CAUSES OF DEATH AMONG ALL AGES (MILLION)
  • FIGURE 23 NUMBER OF COUNTRIES MANDATING FOOD FORTIFICATION, 2010-2024
  • FIGURE 24 NUMBER OF COUNTRIES WITH MANDATORY OR VOLUNTARY FOOD FORTIFICATION, 2021
  • FIGURE 25 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
  • FIGURE 26 AVERAGE SELLING PRICES OF TOP THREE TYPES, 2020-2023 (USD/KG)
  • FIGURE 27 NUTRACEUTICAL INGREDIENTS MARKET: AVERAGE SELLING PRICE TREND, BY REGION (USD/KG)
  • FIGURE 28 NUTRACEUTICAL INGREDIENTS MARKET: VALUE CHAIN ANALYSIS
  • FIGURE 29 KEY PLAYERS IN NUTRACEUTICAL INGREDIENTS ECOSYSTEM
  • FIGURE 30 LIST OF MAJOR PATENTS FOR NUTRACEUTICAL INGREDIENTS MARKET, 2014-2024
  • FIGURE 31 REGIONAL ANALYSIS OF PATENTS GRANTED FOR NUTRACEUTICAL INGREDIENTS MARKET, 2014-2024
  • FIGURE 32 EXPORT VALUE OF NUTRACEUTICAL INGREDIENTS FOR KEY COUNTRIES, 2020-2023 (USD THOUSAND)
  • FIGURE 33 IMPORT VALUE OF NUTRACEUTICAL INGREDIENTS FOR KEY COUNTRIES, 2020-2023 (USD THOUSAND)
  • FIGURE 34 PORTER'S FIVE FORCES ANALYSIS: NUTRACEUTICAL INGREDIENTS MARKET
  • FIGURE 35 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE TYPES
  • FIGURE 36 KEY BUYING CRITERIA FOR TOP THREE TYPES
  • FIGURE 37 INVESTMENT AND FUNDING SCENARIO
  • FIGURE 38 ADOPTION OF GEN AI IN FOOD & BEVERAGE PRODUCTION PROCESS
  • FIGURE 39 NUTRACEUTICAL INGREDIENTS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
  • FIGURE 40 FREQUENCY OF PROBIOTIC CONSUMPTION AMONG USERS
  • FIGURE 41 NUTRACEUTICAL INGREDIENTS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
  • FIGURE 42 NUTRACEUTICAL INGREDIENTS MARKET, BY FORM, 2024 VS. 2029 (USD MILLION)
  • FIGURE 43 BENEFITS SOUGHT FROM FOOD/BEVERAGES/NUTRIENTS IN US
  • FIGURE 44 TOP SPORTS NUTRITION INGREDIENTS SOUGHT BY CONSUMERS IN EUROPE
  • FIGURE 45 INDIA TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • FIGURE 46 NORTH AMERICA: MARKET SNAPSHOT
  • FIGURE 47 ASIA PACIFIC: MARKET SNAPSHOT
  • FIGURE 48 TOP FIVE PLAYERS DOMINATING MARKET, 2019-2023 (USD BILLION)
  • FIGURE 49 SHARE OF LEADING COMPANIES IN NUTRACEUTICAL INGREDIENTS MARKET, 2023
  • FIGURE 50 RANKING OF TOP FIVE PLAYERS IN NUTRACEUTICAL INGREDIENTS MARKET, 2023
  • FIGURE 51 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
  • FIGURE 52 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY FOOTPRINT
  • FIGURE 53 NUTRACEUTICAL INGREDIENTS MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023
  • FIGURE 54 COMPANY VALUATION OF FEW MAJOR PLAYERS (USD BILLION)
  • FIGURE 55 EV/EBITDA OF KEY COMPANIES
  • FIGURE 56 BRAND/PRODUCT COMPARISON
  • FIGURE 57 CARGILL, INCORPORATED: COMPANY SNAPSHOT
  • FIGURE 58 ADM: COMPANY SNAPSHOT
  • FIGURE 59 INTERNATIONAL FLAVORS & FRAGRANCES INC.: COMPANY SNAPSHOT
  • FIGURE 60 BASF SE: COMPANY SNAPSHOT
  • FIGURE 61 ARLA FOODS AMBA: COMPANY SNAPSHOT
  • FIGURE 62 DSM-FIRMENICH: COMPANY SNAPSHOT
  • FIGURE 63 INGREDION: COMPANY SNAPSHOT
  • FIGURE 64 TATE & LYLE: COMPANY SNAPSHOT
  • FIGURE 65 AJINOMOTO CO., INC.: COMPANY SNAPSHOT
  • FIGURE 66 ASSOCIATED BRITISH FOODS PLC: COMPANY SNAPSHOT
  • FIGURE 67 CHR. HANSEN A/S: COMPANY SNAPSHOT
  • FIGURE 68 KYOWA KIRIN CO., LTD: COMPANY SNAPSHOT
  • FIGURE 69 GLANBIA PLC: COMPANY SNAPSHOT
  • FIGURE 70 FONTERRA CO-OPERATIVE GROUP LIMITED: COMPANY SNAPSHOT
  • FIGURE 71 KERRY GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 72 DIVI'S LABORATORIES LIMITED: COMPANY SNAPSHOT